Dopa-responsive dystonia (DRD) encompasses a clinically and genetically heterogeneous group of disorders that typically manifest as limb-onset dystonia that fluctuates diurnally and improves with levodopa treatment. DRD usually results from genetic defects in enzymes that are involved in the biosynthesis of dopamine. The most common condition is autosomal dominant GTP cyclohydrolase 1 deficiency (Segawa syndrome). An autosomal recessive form of Segawa syndrome is caused by mutation in the tyrosine hydroxylase gene.
Category
Nervous system disease
Brite
Human diseases in ICD-11 classification [BR:br08403]
08 Diseases of the nervous system
Movement disorders
8A02 Dystonic disorders
H02557 Dopa-responsive dystonia
Pathway-based classification of diseases [BR:br08402]
Amino acid metabolism
nt06028 Dopamine and serotonin metabolism
H02557 Dopa-responsive dystonia
Cellular process
nt06544 Neuroactive ligand signaling
H02557 Dopa-responsive dystonia